From decreasing insulin prices to using lipid tests to determine patients’ heart disease risk, each week we highlight five things happening in life sciences. … READ MORE >
5 things to know in life sciences: Week of March 6, 2023
From new manufacturing investments to the thriving dog population of Chernobyl, each week we highlight what’s affecting life sciences. Here’s the latest. … READ MORE >
5 things to know in life sciences: Week of Feb. 27, 2023
From a new migraine treatment to the development of a 3D heart replica, each week we highlight what’s happening in life sciences. … READ MORE >
5 things to know in life sciences: Week of Feb. 20, 2023
From a newly approved hemophilia drug to continued concerns about clinical trial diversity, each week we highlight five things affecting life sciences. … READ MORE >
5 things to know in life sciences: Week of Feb. 13, 2023
From guidance on diversity considerations for later-stage clinical trials to a founder-focused biotech fund, here’s what’s happening in life sciences this week. … READ MORE >
5 things to know in life sciences: Week of Feb. 6, 2023
From reducing drug prices to artificial intelligence that provides real-time feedback for cardiac ultrasounds, here’s what’s happening in life sciences. … READ MORE >
5 things to know in life sciences: Week of Jan. 30, 2023
From what’s next for cell and gene therapy companies to new approaches for COVID-19 vaccines, each week we highlight the latest happening in life sciences. … READ MORE >
5 things to know in life sciences: Week of Jan. 23, 2023
From an emerging funding source for biotechs to an app that automates insulin dosing, each week we highlight the latest affecting the life sciences industry. … READ MORE >
5 things to know in life sciences: Week of Jan. 16, 2023
This week we look at growing pharmaceutical manufacturing investment, the potential for a biotech recovery and more. … READ MORE >
5 things to know in life sciences: Week of Jan. 9, 2023
From COVID-19 vaccine proposed pricing increases to changes in the private equity landscape for biopharmas, each week we highlight the latest in life sciences. … READ MORE >